Blackwell reading room · Reviewed November 1, 2026
BPC-157: behind the headlines.
Interesting studies. Big questions. Start with the research, then explore why this experimental peptide keeps coming up in conversation.
BPC-157 is a synthetic peptide made of 15 amino acids. Much of the work discussed here concerns cells and animal models. Those findings are starting points for investigation, not proof of benefits in people.
Three papers worth opening
01 / Laboratory study / 2011
How tendon cells move and respond to stress
Chang and colleagues studied rat tendon tissue and cultured cells. They reported greater cell outgrowth, migration and survival under stress, with changes in FAK-paxillin signaling. Cell proliferation was not directly increased in their assay.
Keep in mind: A useful window into cell behavior, not a demonstration of injury recovery in people.
Read on PubMed02 / Laboratory study / 2014
A closer look at growth hormone receptors
In tendon fibroblasts isolated from rats, researchers reported increased growth hormone receptor expression after BPC-157 exposure. They also examined the cells’ response to added growth hormone and downstream JAK2 signaling.
Keep in mind: Receptor changes in cultured cells do not establish effects on human hormone levels, strength or healing.
Read on PubMed03 / Human evidence review / 2026
What do the human studies actually tell us?
A systematic review found three eligible studies totaling 30 participants. The authors rated the certainty of evidence very low, citing bias, indirectness and imprecision. Small, uncontrolled reports cannot establish effectiveness or long-term safety.
Keep in mind: The authors call for regulated, high-quality clinical trials, rather than clinical use based on the existing evidence.
Read on PubMedWhat people are talking about
Tendon biology, the gap between animal findings and human outcomes, and the difference between popularity and evidence. These articles help put the conversation in context.
Independent reporting / Undark / February 2026
From a Croatian laboratory to the public conversation
Sara Talpos traces BPC-157’s research history, online popularity and policy debate. Reporting adds context; it is not a clinical trial or an endorsement.
Read the articleAthlete education / USADA
Why BPC-157 is a topic in sport
USADA explains the experimental peptide’s prohibited status in sport and why online availability does not establish approval or safety.
Read the articleA better way to read a bold claim
Ask which species was studied, whether there was a comparison group, how many participants were included and how long they were followed. A personal story can raise a question. It cannot, on its own, answer whether a compound works or is safe.